Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells.
Weiss L, Schluck M, Classens R, de Jonge PKJD, van der Waart A, Nguyen KG, Nguyen TT, Zaharoff DA, Malmberg KJ, Dolstra H, Figdor CG, Sohlberg E, Hammink R. Weiss L, et al. Among authors: malmberg kj. Acta Biomater. 2025 Jan 1;191:386-397. doi: 10.1016/j.actbio.2024.11.012. Epub 2024 Nov 9. Acta Biomater. 2025. PMID: 39528061 Free article.
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.
Strunz B, Momayyezi P, Bilev E, Muvva JR, Chen P, Bister J, Schaffer M, Akber M, Cornillet M; Karolinska KI/K COVID-19 Study Group; Horowitz A, Malmberg KJ, Rooyackers O, Aleman S, Ljunggren HG, Björkström NK, Strålin K, Hammer Q. Strunz B, et al. Among authors: malmberg kj. Genes Immun. 2024 Nov 1. doi: 10.1038/s41435-024-00302-6. Online ahead of print. Genes Immun. 2024. PMID: 39487235
Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor.
Sætersmoen M, Kotchetkov IS, Torralba-Raga L, Mansilla-Soto J, Sohlberg E, Krokeide SZ, Hammer Q, Sadelain M, Malmberg KJ. Sætersmoen M, et al. Among authors: malmberg kj. Med. 2024 Oct 17:100521. doi: 10.1016/j.medj.2024.09.010. Online ahead of print. Med. 2024. PMID: 39423821 Free article.
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies.
Hammer Q, Perica K, Mbofung RM, van Ooijen H, Martin KE, Momayyezi P, Varady E, Pan Y, Jelcic M, Groff B, Abujarour R, Krokeide SZ, Lee T, Williams A, Goodridge JP, Valamehr B, Önfelt B, Sadelain M, Malmberg KJ. Hammer Q, et al. Among authors: malmberg kj. Cell Stem Cell. 2024 Sep 5;31(9):1376-1386.e8. doi: 10.1016/j.stem.2024.06.011. Epub 2024 Jul 8. Cell Stem Cell. 2024. PMID: 38981470 Free article.
High-dimensional single-cell analysis of human natural killer cell heterogeneity.
Rebuffet L, Melsen JE, Escalière B, Basurto-Lozada D, Bhandoola A, Björkström NK, Bryceson YT, Castriconi R, Cichocki F, Colonna M, Davis DM, Diefenbach A, Ding Y, Haniffa M, Horowitz A, Lanier LL, Malmberg KJ, Miller JS, Moretta L, Narni-Mancinelli E, O'Neill LAJ, Romagnani C, Ryan DG, Sivori S, Sun D, Vagne C, Vivier E. Rebuffet L, et al. Among authors: malmberg kj. Nat Immunol. 2024 Aug;25(8):1474-1488. doi: 10.1038/s41590-024-01883-0. Epub 2024 Jul 2. Nat Immunol. 2024. PMID: 38956378 Free PMC article.
Engineering immune-evasive allogeneic cellular immunotherapies.
Martin KE, Hammer Q, Perica K, Sadelain M, Malmberg KJ. Martin KE, et al. Among authors: malmberg kj. Nat Rev Immunol. 2024 Sep;24(9):680-693. doi: 10.1038/s41577-024-01022-8. Epub 2024 Apr 24. Nat Rev Immunol. 2024. PMID: 38658708 Review.
164 results